Novozymes A/S (NSIS-B.CO)

DKK 409.4

(-0.8%)

Operating Expenses Summary of Novozymes A/S

  • Novozymes A/S's latest annual operating expenses in 2023 was 5.74 Billion DKK , up 2.12% from previous year.
  • Novozymes A/S's latest quarterly operating expenses in 2024 Q2 was 2.35 Billion DKK , down -0.01% from previous quarter.
  • Novozymes A/S reported a annual operating expenses of 5.14 Billion DKK in annual operating expenses 2022, up 8.67% from previous year.
  • Novozymes A/S reported a annual operating expenses of 4.73 Billion DKK in annual operating expenses 2021, up 11.67% from previous year.
  • Novozymes A/S reported a quarterly operating expenses of 2.35 Billion DKK for 2024 Q1, up 66.47% from previous quarter.
  • Novozymes A/S reported a quarterly operating expenses of 1.3 Billion DKK for 2023 Q1, down -15.06% from previous quarter.

Annual Operating Expenses Chart of Novozymes A/S (2023 - 2013)

Historical Annual Operating Expenses of Novozymes A/S (2023 - 2013)

Year Operating Expenses Operating Expenses Growth
2023 5.74 Billion DKK 2.12%
2022 5.14 Billion DKK 8.67%
2021 4.73 Billion DKK 11.67%
2020 4.24 Billion DKK 1.22%
2019 4.19 Billion DKK -3.9%
2018 4.36 Billion DKK -3.75%
2017 4.53 Billion DKK 6.41%
2016 4.25 Billion DKK -8.51%
2015 4.65 Billion DKK 19.48%
2014 3.89 Billion DKK 0.0%
2013 3.89 Billion DKK 0.0%

Peer Operating Expenses Comparison of Novozymes A/S

Name Operating Expenses Operating Expenses Difference
Flügger group A/S 1.06 Billion DKK -438.453%
Hove A/S 38.81 Million DKK -14702.907%
SP Group A/S 427.15 Million DKK -1245.195%